Until improvements under development can be broadly implemented, routine confirmatory testing in active surveillance for ...

MRI does not reliably exclude clinically significant prostate cancer in about one quarter of patients receiving active surveillance, confirming that MRI is not a substitute for biopsy.

MRI system significantly improves prostate cancer detection and efficiency. Find out how ProAI boosts accuracy and reduces ...

Millions of men could benefit from a new, faster prostate cancer scan. The quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer in clinical trials as the current 30- to ...

A quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, ...

There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next ...

First-of-its-kind partnership between Aidoc and NVIDIA MONAI takes models from lab to scaled clinical use; new Quibim collaboration adds best-in-class Prostate MRI AI NEW YORK, /PRNewswire/ -- Aidoc, ...

Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...

Among patients with prostate cancer who received MRI-guided stereotactic body radiation therapy (SABR), more than 80% demonstrated “classic” neurovascular bundle patterns and over 96% showed more than ...

A landmark £42 million trial aimed at revolutionising prostate cancer screening has officially begun in the UK, with the first eligible men now invited to participate. Health Secretary Wes Streeting ...